Tweede Supplement op het Prospectus d.d. 29 maart 2023 mars 29, 20230CommentsTweede Supplement op het Prospectus d.d. 29 maart 2023 Read More
Derde Supplement op het Prospectus d.d. 29 maart 2023 mars 29, 20230CommentsDerde Supplement op het Prospectus d.d. 29 maart 2023 Read More
Vierde Supplement op het Prospectus d.d. 29 maart 2023 mars 29, 20230CommentsVierde Supplement op het Prospectus d.d. 29 maart 2023 Read More
Vijfde Supplement op het Prospectus d.d. 29 maart 2023 mars 29, 20230CommentsVijfde Supplement op het Prospectus d.d. 29 maart 2023 Read More
New Shares Prospectus – March 29, 2023 mars 29, 20230CommentsProspectus for the admission to trading on Euronext Brussels of up to 1,885,000,000 new shares Read More
First Supplement to the Prospectus of March 29, 2023 mars 29, 20230CommentsFirst Supplement to the Prospectus of March 29, 2023 Read More
Second Supplement to the Prospectus of March 29, 2023 mars 29, 20230CommentsSecond Supplement to the Prospectus of March 29, 2023 Read More
Third Supplement to the Prospectus of March 29, 2023 mars 29, 20230CommentsThird Supplement to the Prospectus of March 29, 2023 Read More
Fourth Supplement to the Prospectus of March 29, 2023 mars 29, 20230CommentsFourth Supplement to the Prospectus of March 29, 2023 Read More
Fifth Supplement to the Prospectus of March 29, 2023 mars 29, 20230CommentsFifth Supplement to the Prospectus of March 29, 2023 Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from ATLAS mars 24, 20230CommentsEN NL Read More
Oxurion Issues EUR 2.8 million in Bonds for Tranche 1 (A) of Funding Program with Atlas Special Opportunities LL mars 20, 20230CommentsEN Read More
Oxurion Provides Update on Recruitment for KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular Edema and Announces Board Changes mars 14, 20230CommentsEN Read More
Beoordelingsverslag van de commissaris aan de Raad van Bestuur – 8 march 2023 mars 8, 20230CommentsAuditor's Report to the Board of Directors (NL only) Read More
Beoordelingsverslag van de commissaris aan de Raad van Bestuur – 8 march 2023 mars 8, 20230CommentsAuditor's Report to the Board of Directors (NL only) Read More
Speciaal verslag van de Raad van Bestuur – 7 maart 2023 mars 7, 20230CommentsSpeciaal verslag van de Raad van Bestuur Read More
Board of Directors Special Report – March 7, 2023 mars 7, 20230CommentsSpecial report of the Board of Directors Read More
Oxurion Announces Subscription Agreement with Atlas Providing the Company with Up To €20 Million in Funding mars 2, 20230CommentsEN Read More
